ScholarIQanswers from OpenAlex
Institute of Rheumatology
InstitutionResearch output, impact & collaborations
Institute of Rheumatology is a institution indexed in ScholarIQ from OpenAlex.
What is known about Institute of Rheumatology?
ScholarIQrecord summary
Institute of Rheumatology is a research organisation in Prague, CZ. OpenAlex records 2,844 works and 231,112 citations for it. 557 researchers list it as their most recent affiliation.
How many works does Institute of Rheumatology have?
ScholarIQindexed works
Institute of Rheumatology has 2,844 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Institute of Rheumatology have?
ScholarIQcitation count
Institute of Rheumatology has 231,112 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Institute of Rheumatology?
ScholarIQresearcher count
Institute of Rheumatology has 557 researchers in the ScholarIQ index.
What is the average h-index at Institute of Rheumatology?
ScholarIQavg h-index
Institute of Rheumatology has an average h-index of 76 in OpenAlex.
What is the ROR of Institute of Rheumatology?
ScholarIQror
The ROR for Institute of Rheumatology is on the source record.
What is the OpenAlex record for Institute of Rheumatology?
ScholarIQopenalex
The OpenAlex for Institute of Rheumatology is on the source record.
Who are the most-cited researchers behind Institute of Rheumatology?
ScholarIQtop researchers by citations
What are the most-cited papers on Institute of Rheumatology?
ScholarIQmost cited works
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh, Stanley Cohen, Karel Pavelká, Ronald van Vollenhoven, John T. Sharp, John L. Perez, G Spencer-Green
\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.
Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, Maxime Dougados, Paul Emery, C. Gaujoux-Viala, Simone Gorter, Rachel Knevel, J. Nam, Monika Schoels, Daniel Aletaha, Maya H Buch, Laure Gossec, T. Huizinga, J. W. J. Bijlsma, Gerd R Burmester, Bernard Combe, Maurizio Cutolo, Cem Gabay, Juan J. Gómez‐Reino, Marios Kouloumas, Tore K Kvien, E. Martín‐Mola, Iain B. McInnes, Karel Pavelká, Piet L. C. M. van Riel, M. Scholte, David L. Scott, Tuulikki Sokka, Guido Valesini, Ronald van Vollenhoven, Kevin Winthrop, John B. Wong, A. Zink, Désirée van der Heijde
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
Linda Fernandes, Kåre Birger Hagen, J. W. J. Bijlsma, Øyvor Andreassen, P. Christensen, Philip G. Conaghan, Michael Doherty, Rinie Geenen, Alison Hammond, Ingvild Kjeken, Stefan Lohmander, Hans Lund, Christian Mallen, Tiziana Nava, Susan Oliver, Karel Pavelká, I. Pitsillidou, José António Pereira da Silva, Jenny de la Torre-Aboki, Gustavo Zanoli, T. P. M. Vliet Vlieland
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
Joseph M. Braun, Rosaline van den Berg, Xenofon Baraliakos, Heinrich Boehm, R Burgos-Vargas, Eduardo Collantes‐Estévez, Hanne Dagfinrud, Ben A. C. Dijkmans, Maxime Dougados, Paul Emery, Pál Géher, M. Hammoudeh, RD Inman, Merryn Jongkees, MA Khan, Uta Kiltz, Tore K Kvien, Marjatta Leirisalo‐Repo, Walter P. Maksymowych, Ignazio Olivieri, Karel Pavelká, J. Sieper, Ewa Stanisławska‐Biernat, Daniel Wendling, Salih Özgöçmen, C van Drogen, Barend J. van Royen, D. van der Heijde
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
Laure Gossec, Josef S Smolen, Sofía Ramiro, M. De Wit, Maurizio Cutolo, Maxime Dougados, Paul Emery, R. Landewé, Susan Oliver, Daniel Aletaha, Neil Betteridge, Jürgen Braun, Gerd R Burmester, Juan D. Cañete, Nemanja Damjanov, Oliver FitzGerald, Emma Haglund, Philip Helliwell, T. K. Kvien, Rik Lories, Thomas A. Luger, Mara Maccarone, Helena Marzo‐Ortega, Dennis McGonagle, Iain B. McInnes, Ignazio Olivieri, Karel Pavelká, Georg Schett, Joachim Sieper, Filip Van den Bosch, Douglas J. Veale, J. Wollenhaupt, A. Zink, Désirée van der Heijde
How much of the research on Institute of Rheumatology is open access?
ScholarIQopen access share
86%OPEN ACCESS